» Articles » PMID: 18339881

Genome-wide Analysis of the Homeobox C6 Transcriptional Network in Prostate Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 2008 Mar 15
PMID 18339881
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Homeobox transcription factors are developmentally regulated genes that play crucial roles in tissue patterning. Homeobox C6 (HOXC6) is overexpressed in prostate cancers and correlated with cancer progression, but the downstream targets of HOXC6 are largely unknown. We have performed genome-wide localization analysis to identify promoters bound by HOXC6 in prostate cancer cells. This analysis identified 468 reproducibly bound promoters whose associated genes are involved in functions such as cell proliferation and apoptosis. We have complemented these data with expression profiling of prostates from mice with homozygous disruption of the Hoxc6 gene to identify 31 direct regulatory target genes of HOXC6. We show that HOXC6 directly regulates expression of bone morphogenic protein 7, fibroblast growth factor receptor 2, insulin-like growth factor binding protein 3, and platelet-derived growth factor receptor alpha (PDGFRA) in prostate cells and indirectly influences the Notch and Wnt signaling pathways in vivo. We further show that inhibition of PDGFRA reduces proliferation of prostate cancer cells, and that overexpression of HOXC6 can overcome the effects of PDGFRA inhibition. HOXC6 regulates genes with both oncogenic and tumor suppressor activities as well as several genes such as CD44 that are important for prostate branching morphogenesis and metastasis to the bone microenvironment.

Citing Articles

HOXC6: A promising biomarker linked to an immunoevasive microenvironment in colorectal cancer based on TCGA analysis and cohort validation.

Weng M, Lai Y, Ge X, Gu W, Zhang X, Li L Heliyon. 2024; 10(1):e23500.

PMID: 38192826 PMC: 10772581. DOI: 10.1016/j.heliyon.2023.e23500.


HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B.

Malvi P, Chava S, Cai G, Hu K, Zhu L, Edwards Y Cell Rep Med. 2023; 4(11):101285.

PMID: 37951219 PMC: 10694669. DOI: 10.1016/j.xcrm.2023.101285.


Expression Profiles of HOXC6 Predict the Survival of Glioblastoma Patients and Correlate with Cell Cycle.

Li Z, Ma Y, Zhou Y, Huang Z J Oncol. 2022; 2022:8656865.

PMID: 35432534 PMC: 9007636. DOI: 10.1155/2022/8656865.


HOXC6-Mediated miR-188-5p Expression Induces Cell Migration through the Inhibition of the Tumor Suppressor FOXN2.

Jeong S, Kim S, Ahn S Int J Mol Sci. 2022; 23(1).

PMID: 35008435 PMC: 8744690. DOI: 10.3390/ijms23010009.


Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer.

Li X, Chen S, Zhu Y, Fei J, Song L, Sun G J Gastrointest Oncol. 2021; 12(5):2132-2149.

PMID: 34790380 PMC: 8576221. DOI: 10.21037/jgo-21-598.


References
1.
Abate-Shen C . Deregulated homeobox gene expression in cancer: cause or consequence?. Nat Rev Cancer. 2002; 2(10):777-85. DOI: 10.1038/nrc907. View

2.
Buck M, Nobel A, Lieb J . ChIPOTle: a user-friendly tool for the analysis of ChIP-chip data. Genome Biol. 2005; 6(11):R97. PMC: 1297653. DOI: 10.1186/gb-2005-6-11-r97. View

3.
Lin Y, Liu G, Zhang Y, Hu Y, Yu K, Lin C . Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis. Development. 2007; 134(4):723-34. DOI: 10.1242/dev.02765. View

4.
Ricort J, Binoux M . Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J Biol Chem. 2002; 277(22):19448-54. DOI: 10.1074/jbc.M200439200. View

5.
Garcia-Gasca A, Spyropoulos D . Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice. Dev Dyn. 2000; 219(2):261-76. DOI: 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1048>3.0.CO;2-3. View